Mei-Juan Wang,Ying-Qian Liu,Ling-Chu Chang,Chih-Ya Wang,Yong-Long Zhao,Xiao-Bo Zhao,Keduo Qian,Xiang Nan,Liu Yang,Xiao-Ming Yang,Hsin-Yi Hung,Jai-Sing Yang,Daih-Huang Kuo,Masuo Goto,Susan L. Morris-Natschke,Shiow-Lin Pan,Che-Ming Teng,Sheng-Chu Kuo,Tian-Shung Wu,Yang-Chang Wu,Kuo-Hsiung Lee

Abstract:Twelve novel 20-sulfonylamidine derivatives (9a–9l) of camptothecin (1) were synthesized via a Cu-catalyzed three-component reaction. They showed similar or superior cytotoxicity compared with that of irinotecan (3) against A-549, DU-145, KB, and multidrug-resistant (MDR) KBvin tumor cell lines. Compound 9a demonstrated better cytotoxicity against MDR cells compared with that of 1 and 3. Mechanistically, 9a induced significant DNA damage by selectively inhibiting Topoisomerase (Topo) I and activating the ATM/Chk related DNA damage-response pathway. In xenograft models, 9a demonstrated significant activity without overt adverse effects at 5 and 10 mg/kg, comparable to 3 at 100 mg/kg. Notably, 9a at 300 mg/kg (i.p.) showed no overt toxicity in contrast to 1 (LD50 56.2 mg/kg, i.p.) and 3 (LD50 177.5 mg/kg, i.p.). Intact 9a inhibited Topo I activity in a cell-free assay in a manner similar to that of 1, confirming that 9a is a new class of Topo I inhibitor. 20-Sulfonylamidine 1-derivative 9a merits development as an anticancer clinical trial candidate.

Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I

Synthesis and biological assays of 9-(acylamino) homocamptothecins as DNA topoisomerase I inhibitors

Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors

Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitors

Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities

Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors

ChemInform Abstract: Synthesis and Evaluation of 9‐benzylideneamino Derivatives of Homocamptothecin As Potent Inhibitors of DNA Topoisomerase I.

Synthesis and Pharmacological Evaluation of Novel Homocamptothecin-Dihydropyridine Derivative Conjugates As Potent Topoisomerase I Inhibitors

Topoisomerase I-mediated antiproliferative activity of 10-substituted and 12-substituted homocamptothecins

Synthesis and Cytotoxicity of Novel 20-O-linked Homocamptothecin Ester Derivatives As Potent Topoisomerase I Inhibitors

Discovery of 7-Methyl-10-hydroxyhomocamptothecins with 1,2,3-Triazole Moiety As Potent Topoisomerase I Inhibitors

ChemInform Abstract: Synthesis and Biological Evaluation of Novel Homocamptothecins Conjugating with Dihydropyrimidine Derivatives As Potent Topoisomerase I Inhibitors.

Synthesis and biological evaluation of new homocamptothecin analogs

Synthesis Of Novel Benzoxanthone Analogues As Non-Camptothecin Topoisomerase I Inhibitors

Design, Synthesis and Biological Evaluation of Novel Homocamptothecin Analogues As Potent Antitumor Agents.

Synthesis and Antitumor Activity of the Hexacyclic Camptothecin Derivatives.

Synthesis and Antitumor Activity of Novel 10-Substituted Camptothecin Analogues.

Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.

Design and One-Pot Synthesis of New 7-Acyl Camptothecin Derivatives As Potent Cytotoxic Agents

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin As Potent Antitumor Agents

Discovery of a Series of Pyridopyrimidine Derivatives As Potential Topoisomerase I Inhibitors